BC
CELG

Barnett & Company’s Celgene Corp CELG Stock Holding History

Barnett & Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,495
Closed -$347K – 524
2019
Q3 		$347K Sell
3,495
-300
-8% -$28.5K 0.2% 78
2019
Q2 		$351K Hold
3,795
– – 0.2% 77
2019
Q1 		$358K Hold
3,795
– – 0.2% 76
2018
Q4 		$243K Sell
3,795
-970
-20% -$71.6K 0.14% 93
2018
Q3 		$426K Hold
4,765
– – 0.19% 81
2018
Q2 		$378K Buy
4,765
+2,865
+151% +$238K 0.18% 89
2018
Q1 		$169K Buy
1,900
+1,270
+202% +$122K 0.09% 124
2017
Q4 		$66K Sell
630
-75
-11% -$8.46K 0.03% 173
2017
Q3 		$103K Sell
705
-125
-15% -$17K 0.05% 144
2017
Q2 		$108K Sell
830
-250
-23% -$30.6K 0.05% 161
2017
Q1 		$134K Sell
1,080
-50
-4% -$5.98K 0.07% 150
2016
Q4 		$131K Hold
1,130
– – 0.07% 168
2016
Q3 		$118K Buy
1,130
+175
+18% +$18.9K 0.06% 176
2016
Q2 		$94K Hold
955
– – 0.05% 178
2016
Q1 		$96K Buy
+955
New +$98.3K 0.05% 182

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Barnett & Company's CELG Position: Q4 2019 in Review

Barnett & Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,495 shares — an estimated $347K sold.

Barnett & Company first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $426K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Barnett & Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Barnett & Company sold 3,495 Celgene Corp shares in Q4 2019, an estimated $347K.
  • Barnett & Company first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Barnett & Company's Celgene Corp position peaked at $426K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Barnett & Company's 13F filing for Q4 2019, filed 22 Jan 2020.